Thursday, April 28, 2011
Attracted by INSERM's large network of
labs and hospitals, MedImmune LLC
has formed a strategic collaboration with the institute to explore
translational biology and novel disease mechanisms with an eye to streamlining
the flow of new discoveries into the clinic.
Lou, K.-J. SciBX
Published online April 28, 2011
COMPANIES AND INSTITUTIONS MENTIONED
AstraZeneca plc (LSE:AZN;
NYSE:AZN), London, U.K.
INSERM Transfert S.A., Paris,
National de la Santé et de la Recherche Médicale, Paris,
MedImmune LLC, Gaithersburg,